相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exercise training delays renal disorders with decreasing oxidative stress and increasing production of 20-hydroxyeicosatetraenoic acid in Dahl salt-sensitive rats
Yoshiko Ogawa et al.
JOURNAL OF HYPERTENSION (2020)
Chronic exercise provides renal-protective effects with upregulation of fatty acid oxidation in the kidney of high fructose-fed rats
Gaizun Hu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats
Asako Namai-Takahashi et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
Sunao Kojima et al.
EUROPEAN HEART JOURNAL (2019)
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study
Lhanoo Gunawardhana et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes
Radko Komers et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia
Kentaro Kohagura et al.
HYPERTENSION RESEARCH (2016)
Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats
Takashi Shirakura et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
Dipankar Sircar et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD)
Akira Sezai et al.
JOURNAL OF CARDIOLOGY (2015)
Allopurinol alleviates hypertension and proteinuria in high fructose, high salt and high fat induced model of metabolic syndrome
Hany M. El-Bassossy et al.
TRANSLATIONAL RESEARCH (2015)
Null Mutation of the Nicotinamide Adenine Dinucleotide Phosphate-Oxidase Subunit p67phox Protects the Dahl-S Rat From Salt-Induced Reductions in Medullary Blood Flow and Glomerular Filtration Rate
Louise C. Evans et al.
HYPERTENSION (2015)
Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension
Catherine J. Beattie et al.
HYPERTENSION (2014)
Four-Week Effects of Allopurinol and Febuxostat Treatments on Blood Pressure and Serum Creatinine Level in Gouty Men
Hyun Ah Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Long-Term Inhibition of Xanthine Oxidase by Febuxostat Does Not Decrease Blood Pressure in Deoxycorticosterone Acetate (DOCA)-Salt Hypertensive Rats
Theodora Szasz et al.
PLOS ONE (2013)
Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress
Hidetoshi Tsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy
Hiroki Omori et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation
Chuang Wang et al.
PLOS ONE (2012)
Impairment of Na/K-ATPase Signaling in Renal Proximal Tubule Contributes to Dahl Salt-sensitive Hypertension
Jiang Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Xanthine Oxidase and Uric Acid in Cardiovascular Disease: Clinical Impact and Therapeutic Options
Wolfram Doehner et al.
SEMINARS IN NEPHROLOGY (2011)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Allopurinol Does Not Decrease Blood Pressure or Prevent the Development of Hypertension in the Deoxycorticosterone Acetate-Salt Rat Model
Theodora Szasz et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension
Niu Tian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension - A randomized trial
Daniel I. Feig et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia
Laura G. Sanchez-Lozada et al.
NEPHRON PHYSIOLOGY (2008)
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome
Laura G. Sanchez-Lozada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions
Mehmet Kanbay et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat
Eiichiro Yamamoto et al.
HYPERTENSION (2007)
Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C
Guillermo B. Silva et al.
HYPERTENSION (2006)
Superoxide radical production by allopurinol and xanthine oxidase
C Galbusera et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation
M Kanazawa et al.
AMERICAN JOURNAL OF HYPERTENSION (2006)
Effect of renal medullary H2O2 on salt-induced hypertension and renal injury
NE Taylor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats
R Hisaki et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle
PX Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
CE Berry et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats
JT Laakso et al.
JOURNAL OF HYPERTENSION (2004)
Oxidative stress in Dahl salt-sensitive hypertension
SM Meng et al.
HYPERTENSION (2003)
Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet
H Kobori et al.
HYPERTENSION (2003)
An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
K Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of abnormal nitric oxide systems in salt-sensitive hypertension
RD Manning et al.
AMERICAN JOURNAL OF HYPERTENSION (2001)
分享论文
